Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1984 1
1985 1
1986 2
1987 2
1989 3
1992 2
1993 2
1996 6
1997 6
1999 2
2002 2
2005 1
2006 1
2007 1
2008 1
2009 5
2010 3
2011 4
2012 11
2013 4
2014 6
2015 9
2016 4
2017 3
2018 3
2019 2
2020 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
The case for wider use of recombinant factor VIII concentrates.
Hermans C, Brackmann HH, Schinco P, Auerswald G. Hermans C, et al. Among authors: schinco p. Crit Rev Oncol Hematol. 2012 Jul;83(1):11-20. doi: 10.1016/j.critrevonc.2011.08.001. Epub 2011 Oct 2. Crit Rev Oncol Hematol. 2012. PMID: 21964312 Review.
Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS).
Fischer K, Lassila R, Peyvandi F, Gatt A, Gouw SC, Hollingsworth R, Lambert T, Kaczmarek R, Carbonero D, Makris M; European HAemophilia Safety Surveillance (EUHASS) participants. Fischer K, et al. Res Pract Thromb Haemost. 2024 May 27;8(4):102461. doi: 10.1016/j.rpth.2024.102461. eCollection 2024 May. Res Pract Thromb Haemost. 2024. PMID: 39026659 Free PMC article.
Current challenges in the diagnosis and management of patients with inherited von Willebrand's disease in Italy: an Expert Meeting Report on the diagnosis and surgical and secondary long-term prophylaxis.
Schinco P, Castaman G, Coppola A, Cultrera D, Ettorre C, Giuffrida AC, Marchesini E, Marino R, Milan M, Molinari C, Siboni SM, Zanon E, Federici AB. Schinco P, et al. Blood Transfus. 2018 Jul;16(4):371-381. doi: 10.2450/2017.0354-16. Epub 2017 May 26. Blood Transfus. 2018. PMID: 29313798 Free PMC article. Review.
Inhibitor development in non-severe haemophilia across Europe.
Fischer K, Iorio A, Lassila R, Peyvandi F, Calizzani G, Gatt A, Lambert T, Windyga J, Gilman EA, Hollingsworth R, Makris M; EUHASS Participants. Fischer K, et al. Thromb Haemost. 2015 Oct;114(4):670-5. doi: 10.1160/TH14-12-1044. Epub 2015 Aug 13. Thromb Haemost. 2015. PMID: 26293381 Free article.
Catastrophic antiphospholipid syndromes in systemic lupus erythematosus.
Stratta P, Canavese C, Ferrero S, Grill A, Salomone M, Schinco PC, Fusaro E, Montaruli B, Santi S, Piccoli G. Stratta P, et al. Among authors: schinco pc. Ren Fail. 1999 Jan;21(1):49-61. doi: 10.3109/08860229909066969. Ren Fail. 1999. PMID: 10048117 Free article. Review.
Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders.
Tagariello G, Iorio A, Santagostino E, Morfini M, Bisson R, Innocenti M, Mancuso ME, Mazzucconi MG, Pasta GL, Radossi P, Rodorigo G, Santoro C, Sartori R, Scaraggi A, Solimeno LP, Mannucci PM; Italian Association Hemophilia Centre (AICE). Tagariello G, et al. Blood. 2009 Jul 23;114(4):779-84. doi: 10.1182/blood-2009-01-195313. Epub 2009 Apr 8. Blood. 2009. PMID: 19357395 Free article. Review.
76 results